Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Curcumin improves blood sugar and cholesterol in PCOS patients.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Switching from escitalopram to duloxetine improved hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Metformin can help prevent the side effects of glucocorticoid medications on metabolism.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Tofacitinib might be used to treat hair loss.

Coix seed extract helped resolve onycholysis in an elderly woman.

New compounds were made that are promising for prostate cancer therapy.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Lowering the dose of cyclosporin caused hair loss that didn't improve even when the dose was increased again.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.